NCT02076672View on ClinicalTrials.gov

Investigation of the Anti-Cancer Activity of Artichoke Extract in an Asbestos-Exposed Population

PHASE2CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

November 5, 2019

Primary Completion Date

April 28, 2020

Study Completion Date

April 28, 2020

Conditions
Asbestos Exposure
Interventions
DRUG

Artichoke WPC

Artichoke WPC 500 mg capsules. Dose = 1000 mg (2 - 500 mg capsules) just before breakfast and 1000 mg (2 - 500 mg capsules) before dinner. Duration: daily for a period of 90 days.

Trial Locations (1)

L8N 4A6

St. Joseph's Hospital, Firestone Institute, Hamilton

All Listed Sponsors
collaborator

Aboca Spa Societa' Agricola

INDUSTRY

lead

Ontario Clinical Oncology Group (OCOG)

OTHER

NCT02076672 - Investigation of the Anti-Cancer Activity of Artichoke Extract in an Asbestos-Exposed Population | Biotech Hunter | Biotech Hunter